Thomas C. Pomeroy

800 total citations
23 papers, 598 citations indexed

About

Thomas C. Pomeroy is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Thomas C. Pomeroy has authored 23 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Thomas C. Pomeroy's work include Sarcoma Diagnosis and Treatment (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Glioma Diagnosis and Treatment (2 papers). Thomas C. Pomeroy is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Glioma Diagnosis and Treatment (2 papers). Thomas C. Pomeroy collaborates with scholars based in United States, Malaysia and Canada. Thomas C. Pomeroy's co-authors include Ralph E. Johnson, Alan S. Rabson, Norman C. Telles, Robert K. Oldham, Henry J. Binder, Riley Kessler, K. Jentzsch, Colin A. Bull, Lynn H. Gerber and Daniel Glaubiger and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Clinical Endocrinology & Metabolism and JNCI Journal of the National Cancer Institute.

In The Last Decade

Thomas C. Pomeroy

22 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas C. Pomeroy United States 15 363 143 127 121 111 23 598
Mark Nesbit United States 14 203 0.6× 70 0.5× 158 1.2× 61 0.5× 90 0.8× 28 771
William L. Thelmo United States 12 204 0.6× 146 1.0× 131 1.0× 43 0.4× 88 0.8× 20 581
J C Ivins United States 8 394 1.1× 88 0.6× 244 1.9× 78 0.6× 221 2.0× 13 523
Strong Lc United States 3 317 0.9× 122 0.9× 200 1.6× 52 0.4× 102 0.9× 4 606
E Glatstein United States 6 435 1.2× 99 0.7× 341 2.7× 158 1.3× 122 1.1× 9 591
Milford D. Schulz United States 13 278 0.8× 308 2.2× 332 2.6× 40 0.3× 78 0.7× 26 717
Marilyn Sonley Canada 15 213 0.6× 197 1.4× 186 1.5× 137 1.1× 44 0.4× 24 832
Riichiro Takanashi Japan 13 187 0.5× 205 1.4× 115 0.9× 102 0.8× 40 0.4× 31 738
M E Nesbit United States 13 499 1.4× 210 1.5× 165 1.3× 153 1.3× 170 1.5× 15 1.1k
Marcove Rc United States 13 677 1.9× 234 1.6× 237 1.9× 150 1.2× 386 3.5× 27 824

Countries citing papers authored by Thomas C. Pomeroy

Since Specialization
Citations

This map shows the geographic impact of Thomas C. Pomeroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Pomeroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Pomeroy more than expected).

Fields of papers citing papers by Thomas C. Pomeroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas C. Pomeroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Pomeroy. The network helps show where Thomas C. Pomeroy may publish in the future.

Co-authorship network of co-authors of Thomas C. Pomeroy

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. Pomeroy. A scholar is included among the top collaborators of Thomas C. Pomeroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. Pomeroy. Thomas C. Pomeroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chou, Jesse, et al.. (1988). Effective radiotherapy in palliating mammalgia associated with gynecomastia after des therapy. International Journal of Radiation Oncology*Biology*Physics. 15(3). 749–751. 21 indexed citations
2.
Mattox, Douglas E., et al.. (1987). Cisplatin and 5-fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of the head and neck. Cancer. 60(11). 2609–2612. 24 indexed citations
3.
Jentzsch, K., Henry J. Binder, Daniel Glaubiger, et al.. (1981). Leg function after radiotherapy for Ewing's sarcoma. Cancer. 47(6). 1267–1278. 69 indexed citations
4.
Datta, Ratna, et al.. (1979). Dosimetry study of split beam technique using megavoltage beams and its clinical implications—I megavoltage beams and its clinical implications—I. International Journal of Radiation Oncology*Biology*Physics. 5(4). 565–571. 15 indexed citations
5.
Richardson, Ronald L., R. K. Oldham, Thomas C. Pomeroy, et al.. (1978). Immunologic monitoring and immunotherapy in Ewing's sarcoma. Cancer Immunology Immunotherapy. 4(2). 2 indexed citations
6.
Telles, Norman C., Alan S. Rabson, & Thomas C. Pomeroy. (1978). Ewing's sarcoma: An autopsy study. Cancer. 41(6). 2321–2329. 49 indexed citations
7.
McCoy, J. L., Lori Jerome, Grace B. Cannon, et al.. (1977). Leukocyte Migration Inhibition in Patients With Ewing's Sarcoma by 3- m Potassium Chloride Extracts of Fresh and Tissue-Cultured Ewing's Sarcomas 2. JNCI Journal of the National Cancer Institute. 59(4). 1119–1125. 10 indexed citations
8.
Djeu, J Y, Susan Payne, W. Heim, et al.. (1977). Detection of decreased proportion of lymphocytes forming rosettes with sheep erythrocytes at 29°C in the blood of cancer patients. Clinical Immunology and Immunopathology. 8(3). 405–419. 21 indexed citations
9.
Spiegel, Allen M., et al.. (1976). Diagnosis of Radiosensitive Hypothalamic Tumors Without Craniotomy. Annals of Internal Medicine. 85(3). 290–293. 19 indexed citations
10.
Ziegler, John L., Vincent T. DeVita, Robert G. Graw, et al.. (1976). Combined modality treatment of American Burkittapos;s lymphoma. Cancer. 38(6). 2225–2231. 25 indexed citations
11.
Pomeroy, Thomas C. & Ralph E. Johnson. (1975). Combined modality therapy of Ewing's sarcoma. Cancer. 35(1). 36–47. 87 indexed citations
12.
Johnson, Ralph E. & Thomas C. Pomeroy. (1975). EVALUATION OF THERAPEUTIC RESULTS IN EWING’S SARCOMA. American Journal of Roentgenology. 123(3). 583–587. 48 indexed citations
13.
Zimbler, Harvey, Gary L. Robertson, Frederic C. Bartter, Catherine S. Delea, & Thomas C. Pomeroy. (1975). Ewing's Sarcoma as a Cause of the Syndrome of Inappropriate Secretion of Antidiuretic Hormone. The Journal of Clinical Endocrinology & Metabolism. 41(2). 390–391. 6 indexed citations
14.
Pomeroy, Thomas C. & Ralph E. Johnson. (1975). PROGNOSTIC FACTORS FOR SURVIVAL IN EWING’S SARCOMA. American Journal of Roentgenology. 123(3). 598–606. 30 indexed citations
15.
Frankel, R., Alfred E. Jones, Jerold A. Cohen, et al.. (1974). Clinical Correlations of67Ga and Skeletal Whole-Body Radionuclide Studies with Radiography in Ewing's Sarcoma. Radiology. 110(3). 597–603. 27 indexed citations
16.
Johnson, Ralph E. & Thomas C. Pomeroy. (1972). INTEGRATED THERAPY FOR EWING'S SARCOMA. American Journal of Roentgenology. 114(3). 532–535. 57 indexed citations
17.
Ullery, John C. & Thomas C. Pomeroy. (1962). Management of Gynecologic Cancer. CA A Cancer Journal for Clinicians. 12(4). 122–138. 1 indexed citations
18.
Pomeroy, Thomas C.. (1957). Fifth Annual Report on Stress, 1955–56. American Journal of Clinical Pathology. 27(1). 95.1–95. 9 indexed citations
19.
Pomeroy, Thomas C.. (1955). Fourth Annual Report on Stress. American Journal of Clinical Pathology. 25(11). 1305.2–1306. 4 indexed citations
20.
Pomeroy, Thomas C.. (1954). Studies on the mechanism of cortisone-induced metastases of transplantable mouse tumors.. PubMed. 14(3). 201–4. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Nesbit Breakdown of academic impact, for papers by William L. Thelmo Breakdown of academic impact, for papers by J C Ivins Breakdown of academic impact, for papers by Strong Lc Breakdown of academic impact, for papers by E Glatstein Breakdown of academic impact, for papers by Milford D. Schulz Breakdown of academic impact, for papers by Marilyn Sonley Breakdown of academic impact, for papers by Riichiro Takanashi Breakdown of academic impact, for papers by M E Nesbit Breakdown of academic impact, for papers by Marcove Rc
Rankless by CCL
2026